Triple versus dual antiplatelet therapy in patients with acute coronary syndrome undergoing primary percutaneous coronary intervention

摘要：

Background Following percutaneous coronary intervention (PCI), clopidogrel therapy in addition to aspirin leads to greater protection from thrombotic complications than aspirin alone.Whether triple antiplatelet therapy is superior or similar to dual antiplatelet therapy in patients with acute coronary syndrome undergoing PCI in the era of drug-eluting stents remains unclear.So we designed this study to evaluate the effect of triple antiplatelet vs dual antiplatelet therapy in patients with acute coronary syndrome after PCI.

作者: HU Bin ZHOU Yu-jie LIU Yuyang SHI Dong-mei ZHAO Yingxin JIA De-an

作者单位: Beijing Anzhen Hospital Affiliated to Capital Medical University Beijing Institute of heart lung and blood vessel diseases

会议类型: 国内会议

会议名称: 第11届中国介入心脏病学大会

会议地点: 北京

会议语种:英文

页码: 203-203

在线出版日期: 2013-03-20（万方平台首次上网日期，不代表论文的发表时间）